• Alnylam's next-gen ATTR amyloidosis drug hits goals in phase 3, teeing up approval filing

    19 days ago - By Fierce Biotech

    Alnylam's next-gen ATTR amyloidosis drug hits goals in phase 3, teeing up approval filing ntaylor
    Thu, 01/07/2021 - 08:11
    Read more ...